超越乳腺癌:选择性雌激素受体调节剂在减少系统性恶性瘤中的作用:基于人口数据的证据
Jeongmin Lee1, Jinyoung Kim2, Chaiho Jeong3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Current medical research and opinion
|August 8, 2024
概括
选择性雌激素受体调节剂 (SERM),如拉洛西芬和巴泽多西芬,可降低绝经后妇女患子宫,卵巢和结直肠癌的风险. 对于子宫内膜癌没有显著的影响,两种药物都显示出类似的结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 选择性雌激素受体调节剂 (SERM),包括拉洛西芬和巴兹多西芬,用于绝经后妇女的骨质疏松症.
- 拉洛西芬以预防乳腺癌而闻名,但其对其他癌症的影响需要调查.
- 这项研究探讨了SERM对骨质疏松症患者各种癌症类型的不明确影响.
研究的目的:
- 调查SERM治疗与绝经后妇女特定癌症发病率之间的关联.
- 为了确定拉洛西芬和巴泽多西芬是否对癌症风险有不同的影响.
- 分析SERM的使用与宫,子宫内膜,卵巢和结直肠癌的发展有关.
主要方法:
- 一项回顾性队列研究,利用来自韩国国家医疗保险服务的数据.
- 在95513名绝经后妇女中使用了倾向性得分匹配,以确保群体的可比性.
- 考克斯的比例危险模型计算了危险比率 (HR) 和95%置信区间 (CI) 来评估癌症风险.
主要成果:
- 治疗SERM与宫癌 (aHR=0.47),卵巢癌 (aHR=0.61) 和结直肠癌 (aHR=0.49) 的风险降低有关.
- 没有观察到子宫内膜癌风险显著降低 (aHR=1.05).
- 拉洛西芬和巴泽多西芬表现出相似的癌症风险降低效果.
结论:
- 治疗SERM与宫,卵巢和结直肠癌的发病率降低有关.
- 发现拉洛西芬和巴泽多西芬的抗癌作用是一致的.
- 需要进一步的研究来了解这些发现的潜在机制和临床影响.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


